AmplifyBio

Hilliard, United States Founded: 2021 • Age: 5 yrs
Provides contract research, development, and manufacturing services for biologic drugs.
Request Access

About AmplifyBio

AmplifyBio is a company based in Hilliard (United States) founded in 2021. It operates as a B2B. AmplifyBio has raised $229.75 million across 4 funding rounds from investors including Hercules Capital. AmplifyBio operates in a competitive market with competitors including Novartis, Catalent, Surrozen, Biotage and Curia, among others.

  • Headquarter Hilliard, United States
  • Sectors
    Healthcare
  • Phone
    *********
  • Website
    *********
  • Social
    *********
Operational Areas
Healthcare → Healthcare Services & Infrastructure
Key Metrics
  • Annual Revenue
  • Net Profit
  • EBITDA
  • Total Equity Funding
    $229.75 M (USD)

    in 4 rounds

  • Latest Funding Round
    $49.75 M (USD), Series C

    Oct 31, 2023

  • Investors
  • Employee Count
    Employee Count
Upgrade to premium

Unlock complete access to The Company Check

Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.

Upgrade to Premium No viewing limits. Your plan controls exports and screening usage.
Included in your Premium account
  • Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
  • Full access to every database India & global coverage, advanced filters and rich profile details
  • Always-on access from your team account Single premium plan for everything you see on the portal
People of AmplifyBio
Headcount 200-500
Employee Profiles 15
Board Members and Advisors 4
Employee Profiles
People
Jerry Hacker
EVP & Chief Commercial Officer
People
Mark Perry
Director of Business Development
People
J. Kelly Ganjei
President & CEO
People
Dean Kobs
Vice President Of CRO Operations

Unlock access to complete

Board Members and Advisors
people
Matt Vaughan
Director
people
Rohan Nirody
Director
people
Shaun Rodriguez
Director
people
Lewis Von Thaer
Director

Unlock access to complete

Funding Insights of AmplifyBio

AmplifyBio has successfully raised a total of $229.75M across 4 strategic funding rounds. The most recent funding activity was a Series C round of $49.75 million completed in October 2023. This substantial capital infusion reflects strong investor confidence in the company's business model, growth potential, and market opportunities. The funding enables strategic expansion, product development, market penetration, and operational scaling to drive long-term value creation and competitive advantage.

  • Total Funding
  • Total Rounds 4
  • Last Round Series C — $49.8M
  • First Round

    (22 May 2021)

  • Investors Count 1
Date Amount Transaction Name Valuation Lead Investors Investors
Oct, 2023 Amount Series C - AmplifyBio Valuation

investors

Jan, 2023 Amount Debt – Conventional - AmplifyBio Valuation

investors

Apr, 2022 Amount Series C - AmplifyBio Valuation

investors

Date Amount Transaction Name Valuation Lead Investors Investors
Jul, 2021 Amount Post-IPO - Grab Valuation

investors

Feb, 2021 Amount Post-IPO - Grab Valuation

investors

Jan, 2021 Amount Post-IPO - Grab Valuation

investors

Feb, 2021 Amount Post-IPO - Grab Valuation

investors

Investors in AmplifyBio

AmplifyBio has secured backing from 1 investor, including venture fund investors. Prominent investors backing the company include Hercules Capital. This diverse investor base provides strategic capital, industry expertise, and valuable network connections that support the company's growth initiatives, market expansion, and long-term value creation.

All
Venture Fund
Investor Description Founded Year Domain Location
Venture debt financing is provided to companies in multiple sectors.
Founded Year Domain Location
Investor Description Founded Year Domain Location
Single family office of Amitabh Bachchan, founder of Amitabh Bachchan Corporation or AB CORP
Founded Year Domain Location
Startup ecosystems are ignited through strategic investments by Signite Partners.
Founded Year Domain Location
Venture capital is directed toward companies in multiple sectors.
Founded Year Domain Location
Venture capital is invested in cybersecurity, fintech, and AI startups.
Founded Year Domain Location

Investments & Acquisitions by AmplifyBio

Investments
Company Name Description Domain Location Founded Year Amount
Bionic investment advisor platform
2016
Fine Asian gourmet food is offered by an internet-first restaurant.
2016
Physical e-commerce kiosks are deployed for rural purchases in Indonesia.
2014
Fine Asian gourmet food is offered by an internet-first restaurant.
2016

Financial Statements - AmplifyBio

Tata Steel revenue growth over time
Tata Steel profit and loss trends over time
Date Amount Transaction Name Valuation Lead Investors Investors
Jul, 2021 Amount Post-IPO - Grab Valuation

investors

Feb, 2021 Amount Post-IPO - Grab Valuation

investors

Jan, 2021 Amount Post-IPO - Grab Valuation

investors

Feb, 2021 Amount Post-IPO - Grab Valuation

investors

Amplifybio Comparisons

Employees
+
Add Comparison
Available on Premium

Competitors of AmplifyBio

AmplifyBio operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as Novartis, Catalent, Surrozen, Biotage and Curia, among others. This competitive environment drives innovation, market differentiation, and strategic positioning as companies strive to capture market share and deliver value to their customers. Understanding the competitive dynamics is crucial for assessing market positioning, identifying growth opportunities, and navigating the challenges inherent in a competitive marketplace.

Company Name Domain Founded year HQ Location Description
domain founded_year HQ Location
R&D focused on manufacturing of drugs for multiple therapeutic areas
domain founded_year HQ Location
CDMO offering drug and biologics development services
domain founded_year HQ Location
Selective Wnt agonists are developed for human tissue regeneration.
domain founded_year HQ Location
Organic synthesis, analytical, and peptide chemistry services for drug discovery and development
domain founded_year HQ Location
Drug research, development, testing, and consulting services are provided.
domain founded_year HQ Location
Protein therapeutics are developed and manufactured by WuXi Biologics.
Company Name Domain Founded year HQ Location Description
domain founded_year HQ Location
Multiple services are booked via an app-based platform.
domain founded_year HQ Location
On-demand services are booked through an app-based platform.
domain founded_year HQ Location
App based platform offering on demand delivery and ride-hailing services
domain founded_year HQ Location
Operates an on-demand hyperlocal delivery app for food and groceries.

Latest news on Amplifybio

Frequently Asked Questions about AmplifyBio

When was AmplifyBio founded?

AmplifyBio was founded in 2021.

Where is AmplifyBio located?

AmplifyBio is headquartered in Hilliard, United States. It is registered at Hilliard, Ohio, United States.

Is AmplifyBio a funded company?

AmplifyBio is a funded company, having raised a total of $229.75M across 4 funding rounds to date. The company's 1st funding round was a Series C of $100M, raised on May 22, 2021.

What does AmplifyBio do?

AmplifyBio provides contract research, development, and manufacturing services for biologic drugs through providing healthcare solutions, advancing biotech innovations, drug development, and contract manufacturing. Prioritizing client-centric approaches, it ensures high-quality outcomes, innovation, and sustainable practices in its field. It continues to evolve, meeting industry challenges with strategic approaches.

Who are the top competitors of AmplifyBio?

AmplifyBio's top competitors include Novartis, Surrozen and Catalent.

Who are AmplifyBio's investors?

AmplifyBio has 1 investor. Key investors include Hercules Capital.

Explore millions of companies — effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals — all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available